1-11 of 11
Douglas M. Potter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

Hideho Okada, Lisa H. Butterfield, Ronald L. Hamilton, Aki Hoji, Masashi Sakaki, Brian J. Ahn, Gary Kohanbash, Jan Drappatz, Johnathan Engh, Nduka Amankulor, Mark O. Lively, Michael D. Chan, Andres M. Salazar, Edward G. Shaw, Douglas M. Potter, Frank S. Lieberman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 286–294.
https://doi.org/10.1158/1078-0432.CCR-14-1790
Published: 14 January 2015
View article titled, Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
Open the PDF for Induction of Robust Type-I CD8<sup>+</sup> T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC in another window
Includes: Supplementary data
Journal Articles

LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

Jacky T. Yeung, Ronald L. Hamilton, Koji Ohnishi, Maki Ikeura, Douglas M. Potter, Marina N. Nikiforova, Soldano Ferrone, Regina I. Jakacki, Ian F. Pollack, Hideho Okada
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1816–1826.
https://doi.org/10.1158/1078-0432.CCR-12-2861
Published: 02 April 2013
View article titled, LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma
Open the PDF for LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Lisa H. Butterfield, A. Karolina Palucka, Cedrik M. Britten, Madhav V. Dhodapkar, Leif Håkansson, Sylvia Janetzki, Yutaka Kawakami, Thomas-Oliver Kleen, Peter P. Lee, Cristina Maccalli, Holden T. Maecker, Vernon C. Maino, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Graham Pawelec, Douglas M. Potter, Licia Rivoltini, Lupe G. Salazar, Dolores J. Schendel, Craig L. Slingluff, Jr, Wenru Song, David F. Stroncek, Hideaki Tahara, Magdalena Thurin, Giorgio Trinchieri, Sjoerd H. van Der Burg, Theresa L. Whiteside, Jon M. Wigginton, Francesco Marincola, Samir Khleif, Bernard A. Fox, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3064–3076.
https://doi.org/10.1158/1078-0432.CCR-10-2234
Published: 15 May 2011
View article titled, Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Open the PDF for Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers in another window
Journal Articles

A Phase I Study of 17-Allylamino-17-Demethoxygeldanamycin Combined with Paclitaxel in Patients with Advanced Solid Malignancies

Suresh S. Ramalingam, Merrill J. Egorin, Ramesh K. Ramanathan, Scot C. Remick, Rachel P. Sikorski, Theodore F. Lagattuta, Gurkamal S. Chatta, David M. Friedland, Ronald G. Stoller, Douglas M. Potter, S. Percy Ivy, Chandra P. Belani
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3456–3461.
https://doi.org/10.1158/1078-0432.CCR-07-5088
Published: 02 June 2008
View article titled, A Phase I Study of 17-Allylamino-17-Demethoxygeldanamycin Combined with Paclitaxel in Patients with Advanced Solid Malignancies
Open the PDF for A Phase I Study of 17-Allylamino-17-Demethoxygeldanamycin Combined with Paclitaxel in Patients with Advanced Solid Malignancies in another window
Journal Articles

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Suresh S. Ramalingam, Robert A. Parise, Ramesh K. Ramananthan, Theodore F. Lagattuta, Lori A. Musguire, Ronald G. Stoller, Douglas M. Potter, Athanassios E. Argiris, James A. Zwiebel, Merrill J. Egorin, Chandra P. Belani
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (12): 3605–3610.
https://doi.org/10.1158/1078-0432.CCR-07-0162
Published: 15 June 2007
View article titled, Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies
Open the PDF for Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies in another window
Journal Articles

Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers

Ramesh K. Ramanathan, Merrill J. Egorin, Julie L. Eiseman, Suresh Ramalingam, David Friedland, Sanjiv S. Agarwala, S. Percy Ivy, Douglas M. Potter, Gurkamal Chatta, Eleanor G. Zuhowski, Ronald G. Stoller, Cynthia Naret, Jianxia Guo, Chandra P. Belani
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1769–1774.
https://doi.org/10.1158/1078-0432.CCR-06-2233
Published: 15 March 2007
View article titled, Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers
Open the PDF for Phase I and Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients with Refractory Advanced Cancers in another window
Journal Articles

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

Lisa H. Butterfield, Antoni Ribas, Vivian B. Dissette, Yohan Lee, Jin Quan Yang, Pilar De la Rocha, Sonia D. Duran, Jackie Hernandez, Elisabeth Seja, Douglas M. Potter, William H. McBride, Richard Finn, John A. Glaspy, James S. Economou
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2817–2825.
https://doi.org/10.1158/1078-0432.CCR-05-2856
Published: 04 May 2006
View article titled, A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides
Open the PDF for A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides in another window
Journal Articles

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers

Ramesh K. Ramanathan, Donald L. Trump, Julie L. Eiseman, Chandra P. Belani, Sanjiv S. Agarwala, Eleanor G. Zuhowski, Jing Lan, Douglas M. Potter, S. Percy Ivy, Sakkaraiappan Ramalingam, Adam M. Brufsky, Michael K.K. Wong, Susan Tutchko, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3385–3391.
https://doi.org/10.1158/1078-0432.CCR-04-2322
Published: 02 May 2005
View article titled, Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers
Open the PDF for Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers in another window
Journal Articles

Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors

William C. Zamboni, Laura L. Jung, Merrill J. Egorin, Douglas M. Potter, David M. Friedland, Chandra P. Belani, Sanjiv S. Agarwala, Michael M. W. Wong, Marwan Fakih, Donald L. Trump, Ruzhi Jin, Sandra Strychor, Michael Vozniak, Monica Troetschel, Ramesh K. Ramanathan
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5058–5064.
https://doi.org/10.1158/1078-0432.CCR-03-0288
Published: 05 August 2004
View article titled, Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors
Open the PDF for Phase I and Pharmacologic Study of Intermittently Administered 9-Nitrocamptothecin in Patients with Advanced Solid Tumors in another window
Journal Articles

Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin

William C. Zamboni, Anne C. Gervais, Merrill J. Egorin, Jan H. M. Schellens, Deborah R. Hamburger, Brian J. Delauter, Amy Grim, Eleanor G. Zuhowski, Erin Joseph, Dick Pluim, Douglas M. Potter, Julie L. Eiseman
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 2992–2999.
Published: 01 September 2002
View article titled, Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin
Open the PDF for Inter- and Intratumoral Disposition of Platinum in Solid Tumors after Administration of Cisplatin in another window
Journal Articles

Pharmacodynamic Model of Topotecan-induced Time Course of Neutropenia

William C. Zamboni, David Z. D’Argenio, Clinton F. Stewart, Tom MacVittie, Brian J. Delauter, Ann M. Farese, Douglas M. Potter, Nacole M. Kubat, David Tubergen, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2301–2308.
Published: 01 August 2001
View article titled, Pharmacodynamic Model of Topotecan-induced Time Course of Neutropenia
Open the PDF for Pharmacodynamic Model of Topotecan-induced Time Course of Neutropenia in another window